The Journal.The Wall Street Journal & Spotify Studios
Qrativ's Murali Aravamudan on "What's Possible" for AI in Drug Discovery
- Forfatter
- Afsnit
- 243
- Udgivet
- 14. okt. 2017
- Forlag
- 0 Anmeldelser
- 0
- Afsnit
- 243 of 1197
- Længde
- 26M
- Sprog
- Engelsk
- Format
- Kategori
- Økonomi & Business
In this episode, we talk to Murali Aravamudan, Founder and CEO of AI-driven drug discovery startup Qrativ, a joint venture by the Mayo Clinic and biotech/data science firm reference. Murali and I discuss the surge of medical information and data in the medical industry, the role of artificial intelligence in developing drugs for treatments to various diseases, and the future of AI in drug discovery. For more in-depth interviews on the business applications of artificial intelligence, find us online at: www.TechEmergence.com
Other podcasts you might like ...
- The Journal.The Wall Street Journal & Spotify Studios
- The Can Do WayTheCanDoWay
- HW News Business Tit-BitsHW News Network
- 1,5 graderAndreas Bäckäng
- Self-Compassionate ProfessorPhD
- Networth and Chill with Your Rich BFFVivian Tu
- Don't Be SourMaxx Chewning
- Mark My Words PodcastMark Homer
- EGO NetCastMartin Lindeskog
- The Pathless Path with Paul MillerdPaul Millerd
